ARTICLE | Financial News
Adynxx raises $16M in series B
January 10, 2017 11:59 PM UTC
Pain company Adynxx Inc. (San Francisco, Calif.) raised $16 million in a series B round led by new investor TPG Biotech. Existing investor Domain Associates also participated.
Adynxx said it plans to start a Phase II study of lead program AYX1 to prevent chronic pain following surgery. The company did not respond to an inquiry about the trial's timeline. AYX1 is a small synthetic dsDNA inhibitor of early growth response 1 (EGR1)...
BCIQ Company Profiles
BCIQ Target Profiles